CDC20 and hepatocellular carcinoma: Moreover, significance of CDC20 in HCC prognosis was validated by realtime PCR data from our cohort of 76 HCC patients, and the patients in the CDC20 high group exhibited shorter survival time than those patients in CDC20 low group (median OS time were 37 and 45 months, respectively; difference=8 months; p<0.05) as shown in Figure 3D.